Publicacións en colaboración con investigadores/as de Royal Holloway University of London (10)

2024

  1. Evidence-based definition of hypoprolactinemia in European men aged 40–86 years: the European male ageing study

    Reviews in Endocrine and Metabolic Disorders

  2. The relationship between low prolactin and type 2 diabetes

    Reviews in Endocrine and Metabolic Disorders

2022

  1. Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men: The European Male Ageing Study.

    Physiology and Behavior, Vol. 252

2018

  1. Elevated luteinizing hormone despite normal testosterone levels in older men—natural history, risk factors and clinical features

    Clinical Endocrinology, Vol. 88, Núm. 3, pp. 479-490

  2. Reproductive hormone levels predict changes in frailty status in community-dwelling older men: European male ageing study prospective data

    Journal of Clinical Endocrinology and Metabolism, Vol. 103, Núm. 2, pp. 701-709

  3. Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMAS

    Clinical Endocrinology, Vol. 89, Núm. 4, pp. 459-469

2017

  1. Changes in prevalence of obesity and high waist circumference over four years across European regions: the European male ageing study (EMAS)

    Endocrine, Vol. 55, Núm. 2, pp. 456-469

  2. Frailty and bone health in European men

    Age and Ageing, Vol. 46, Núm. 4, pp. 635-641

  3. Nonandrogenic anabolic hormones predict risk of frailty: European male ageing study prospective data

    Journal of Clinical Endocrinology and Metabolism, Vol. 102, Núm. 8, pp. 2798-2806

2016

  1. Natural history, risk factors and clinical features of primary hypogonadism in ageing men: Longitudinal Data from the European Male Ageing Study

    Clinical Endocrinology, Vol. 85, Núm. 6, pp. 891-901